Icon selects AG Mednet to give trial sponsors zero-delay efficiency

Wednesday, June 27, 2012 09:23 AM

AG Mednet has signed an OEM agreement with Icon Medical Imaging, a division of Icon, further embedding AG Mednet’s quality control, compliance, de-identification and image transfer technology into Icon’s imaging trial offerings.

AG Mednet provides the quality assurance and compliance technology necessary for clinical trials to operate with zero delay. The OEM partnership with AG Mednet provides Icon Medical Imaging with early insight into AG Mednet technology advancements for expanded capabilities, and will provide Icon’s imaging clients with a more efficient, compliant and cost-effective clinical trial system to expedite the clinical trial decision-making process. 

AG Mednet’s technology and services will integrate with Icon’s MIRA and CTMS to provide sponsors and sites with the most advanced image data collection and delivery system in the market. AG Mednet supports all organizations in the clinical trial ecosystem: core labs, clinical research organizations, pharmaceutical companies and principal investigators.  

“This OEM agreement is the culmination of years of collaboration and hard work between our companies,” said Abraham Gutman, president and CEO of AG Mednet. “Icon Medical Imaging has a far-reaching quality management vision that will reduce the burden on sites, increase trial efficiency and strengthen protocol compliance across all therapeutic areas.” 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 22

DaVita combines its two research CRO units to create an end-to-end CRO focused on kidney, end-stage renal disease

New crop of clinical trial matching services use patient’s molecular, genomic data for better fit

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs